By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
The Tech MarketerThe Tech MarketerThe Tech Marketer
  • Home
  • Technology
  • Entertainment
    • Memes
    • Quiz
  • Marketing
  • Politics
  • Visionary Vault
    • Whitepaper
Reading: Precision Where It Counts: Evaluating 5-DOF EM Tracking Sensor Performance for Minimally Invasive Navigation Systems – Quasar Medical
Share
Notification Show More
Font ResizerAa
The Tech MarketerThe Tech Marketer
Font ResizerAa
  • Home
  • Technology
  • Entertainment
  • Marketing
  • Politics
  • Visionary Vault
  • Home
  • Technology
  • Entertainment
    • Memes
    • Quiz
  • Marketing
  • Politics
  • Visionary Vault
    • Whitepaper
Have an existing account? Sign In
Follow US
© The Tech Marketer. All Rights Reserved.
White Paper

Precision Where It Counts: Evaluating 5-DOF EM Tracking Sensor Performance for Minimally Invasive Navigation Systems – Quasar Medical

thetechmarketer
Last updated:
thetechmarketer 1 hour ago
Share
SHARE

INTRODUCTION

In minimally invasive procedures, knowing exactly where a catheter is matters. Electromagnetic tracking systems make real-time navigation possible without line-of-sight constraints, but their accuracy depends entirely on the sensors embedded within those instruments. As device OEMs push toward smaller, more capable navigation platforms, the question of which sensors can reliably deliver sub-millimeter positional performance becomes a critical design decision.

This whitepaper from Quasar Medical presents an independent, bench-level performance evaluation of two Quasar-developed 5-DOF EM tracking sensors against commercially available reference sensors. Conducted by third-party testing organization Quadrant Scientific using an NDI Aurora Planar 20-20 V2 field generator, the study assesses positional accuracy, orientation accuracy, and stability under identical conditions — giving medical device engineers a data-driven framework for comparing sensor candidates before design lock.


YOU WILL LEARN

  • Why positional RMS error, angular error, jitter, and drift are the right metrics to evaluate catheter-scale EM sensor performance
  • How two Quasar sensors (Oz and Neptune) compared to commercially available reference sensors under identical calibration and test conditions
  • What normalized sensitivity characterization reveals about manufacturing consistency across sensor populations
  • How robotic gantry positioning eliminates operator variability and enables high-confidence spatial accuracy measurements
  • Why all sensors being tested on the same calibration file (ROM) is essential for direct performance comparison
  • What “comparable performance” actually means in numbers: RMS positional error, mean error, standard deviation, jitter, and drift values side by side
  • How angular accuracy results differed between the two Quasar sensor models relative to their respective reference sensors
  • What the study’s scope and limitations mean for OEMs evaluating these sensors for finished-device integration
  • How Quasar Medical’s CDMO model supports sensor development from prototype through commercial production

STRATEGIC INSIGHT SECTION

Strategic Insight: Independent Validation Changes the Sensor Selection Conversation

Third-Party Testing Removes Ambiguity from Supplier Claims

The evaluation was conducted by Quadrant Scientific, an independent sensor testing and appraisal organization with no financial stake in the outcome. All sensors — Quasar-developed and commercially sourced reference sensors — were tested under identical excitation, calibration, and positioning conditions. This methodology removes the most common objection in supplier evaluations: that performance data was generated under favorable conditions. For OEMs, that means the numbers in this study are a direct comparative input, not marketing copy.

The Data Is Specific Enough to Matter

Quasar Oz demonstrated an RMS positional error of 1.18 mm versus 1.24 mm for Reference Sensor A — a difference of approximately 4.8%. Quasar Neptune came in at 1.11 mm RMS positional error against Reference Sensor B at 1.07 mm, a difference of roughly 3.7%. Angular error, jitter, and drift results followed the same pattern: differences within the same order of magnitude, with both Quasar sensors tracking within the sensitivity characterization ranges established during manufacturing population analysis. These are the kinds of figures that belong in a design input document.

Sensor Consistency Starts at Manufacturing

Both Quasar sensor populations (Oz and Neptune) demonstrated normalized electrical sensitivity values within a specified +/-5% window. Median sensitivity for Neptune was 1.0075; for Oz, 1.0040. That consistency matters not just for qualification but for predicting unit-to-unit variation in production — a parameter OEMs need to model when designing catheter-scale devices where sensor interchangeability is a regulatory and operational requirement.

What the Study Does Not Claim

The whitepaper is explicit: results apply only to the defined test conditions and are not intended to represent performance under dynamic motion, clinical, or in vivo use scenarios. No inter-operator variability study was conducted, and long-term aging or drift over extended use was not evaluated. This kind of scope transparency is itself a signal about how the data should be used — and how Quasar Medical positions itself as a development partner rather than just a component supplier.


GOVERNANCE / CHALLENGES

Integrating miniature EM sensors into catheter-scale devices requires navigating regulatory design controls under FDA 21 CFR Part 807 and EU MDR 2017/745 — the sensor component does not carry independent clearance. OEMs must validate performance within their specific finished-device context, meaning bench-level comparative data is a starting point, not an endpoint. Environmental variables including ferromagnetic distorters, alternate field generator models, and EM interference can alter tracking performance in ways that static laboratory evaluations cannot fully characterize. Sensor performance must also hold across manufacturing lot variation, making sensitivity population data as important as single-unit accuracy results.


IMPLEMENTATION / STRATEGY

For OEMs evaluating EM sensor suppliers, the path from bench data to design selection involves matching the test conditions in this study to your own system architecture — field generator model, measurement volume, and calibration approach all influence how results translate. Quasar Medical’s CDMO model is structured to support that process, from custom sensor development through sensor integration, prototype builds, and commercial production. The whitepaper’s underlying calibration records and methodology documentation are available on request, giving engineering teams the technical depth needed for their own design verification and validation activities.


WHO SHOULD READ THIS

This whitepaper is written for medical device engineers, systems architects, and R&D leaders at OEMs developing catheter-based navigation products, image-guided intervention platforms, or minimally invasive surgical systems that rely on EM tracking. It is equally relevant for regulatory affairs and quality teams evaluating supplier technical documentation as part of design control processes, and for procurement and strategic sourcing professionals comparing sensor component suppliers for new platform development.


FINAL CTA

Download Evaluating 5-DOF EM Tracking Sensor Performance for Minimally Invasive Navigation Systems from Quasar Medical to access the full comparative performance data, test methodology, and sensor characterization results needed to inform your EM sensor selection and design integration process.

You Might Also Like

The Wrong Microscope Costs More Than the Right One: Key Factors to Consider When Selecting a Stereo Microscope – Leica Microsystems

What 2D Spatial Biology Is Leaving on the Table: The Next Dimension of Discovery: Advancing Spatial Biology in Three Dimensions – Stellaromics

Disconnected Systems Are Costing You More Than You Think: The Operations Health Check for Canadian Manufacturers – Odoo

Buying Smart, Not Just Buying Big: Biopharma Guide: Future-Proof Your Confocal Microscopy Platform Investment – Leica Microsystems

From 85% to 88% OTIF — and Climbing: National DCP: How ORTEC supports a scalable national supply chain – ORTEC

Share This Article
Facebook LinkedIn Email Copy Link Print
Share
What do you think?
Love0
Sad0
Happy0
Sleepy0
Angry0
Dead0
Wink0
Previous Article Celtics vs Nuggets NBA game on November 18, 2026 at Ball Arena Celtics vs Nuggets: Denver Erases 17-Point Deficit to Beat Boston 105-101 in Dramatic NBA Finish
Next Article The Wrong Microscope Costs More Than the Right One: Key Factors to Consider When Selecting a Stereo Microscope – Leica Microsystems
Leave a comment

Leave a Reply Cancel reply

You must be logged in to post a comment.

Latest News

  • Roblox money is pushing a controversial anorexia treatment

    In a dark room, a man with a camera makes his pitch: Therapy isn't the first treatment you should get if you have anorexia or bulimia, he says. He's in his late 20s, wearing a backward camo baseball cap and a silver chain. "Instead of going straight to the therapy, let's do a keto diet

  • Elon Musk tries to explain what’s going on with Ukraine and Starlink

    Elon Musk said Ukrainian president Volodymyr Zelenskyy is lying about disruptions to Starshield in Ukraine and that he's trying to misuse SpaceX's consumer service, Starlink, for military purposes. Musk made the comments at The New York Times' DealBook Summit on Wednesday as he tried to explain the conflict following weeks of back and forth between

  • The nation’s largest school districts consider ditching Google Search

    New York, Los Angeles, and Chicago schools are considering Google alternatives after the company said it will disable Search for schools that opt out of its AI features, according to The New York Times. Starting next year, schools will not have the option to disable Gemini-powered features without also disabling Search. Chris Phillips, Google's vice

  • Democrats skip a vote on adding Brendan Carr’s adviser to the FCC

    Senate commerce committee Chair Ted Cruz (R-TX) began a meeting Wednesday meant to confirm President Donald Trump's nominee to the Federal Communications Commission with a lopsided dais. To his right sat all 14 Republican members of the panel, including Senate Majority Leader John Thune (R-SD). To his left were about a dozen empty chairs -

  • Absolute Batman can save DC Studios

    With James Gunn and Peter Safran out as the co-heads of DC Studios following Skydance's acquisition of Warner Bros. Discovery, it's unclear what will become of the cinematic universe that was building around movies like last year's Superman. Though Gunn's Man of Tomorrow feature might still come out, it seems like his larger vision for

- Advertisement -
about us

We influence 20 million users and is the number one business and technology news network on the planet.

Advertise

  • Advertise With Us
  • Newsletters
  • Partnerships
  • Brand Collaborations
  • Press Enquiries

Top Categories

  • Artificial Intelligence
  • Technology
  • Bussiness
  • Politics
  • Marketing
  • Science
  • Sports
  • White Paper

Legal

  • About Us
  • Contact Us
  • Privacy Policy
  • Affiliate Disclaimer
  • Legal

Find Us on Socials

The Tech MarketerThe Tech Marketer
© The Tech Marketer. All Rights Reserved.
Welcome Back!

Sign in to your account

Lost your password?